Stock Events

Arrowhead Pharmaceuticals (A2RR34.SA) Q3 2017 Earnings

3AugConfirmed
Q4 2016
Q1 2017
Q2 2017
Q3 2017
-1.15
-0.84
-0.53
-0.22

Details

Expected EPS
-0.43561000000000005
Actual EPS
-0.21780500000000003
Surprise EPS
0.22
Surprise Percent
+50%

Description

Arrowhead Pharmaceuticals (A2RR34.SA) has reported earnings of -0.21780500000000003 per share for Q3 2017.

0 Comments

Share your thoughts